Taken together, we identified a potential regulatory mechanism of p16INK4a/MMP-2 expression in cancer by loss of function of p21WAF1/Cip1 through the interaction with hYSK1 in hypoxia (Figure 6). Here, CDKN2A is linked to cancer.